Tags

Type your tag names separated by a space and hit enter

Neutralizing SARS-CoV-2.
Elife. 2020 12 15; 9E

Abstract

Experiments with hybrid viruses are illuminating how SARS-CoV-2 can escape neutralizing antibodies.

Authors+Show Affiliations

Division of Infectious Diseases, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, United States.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33320086

Citation

Poeschla, Eric. "Neutralizing SARS-CoV-2." ELife, vol. 9, 2020.
Poeschla E. Neutralizing SARS-CoV-2. Elife. 2020;9.
Poeschla, E. (2020). Neutralizing SARS-CoV-2. ELife, 9. https://doi.org/10.7554/eLife.64496
Poeschla E. Neutralizing SARS-CoV-2. Elife. 2020 12 15;9 PubMed PMID: 33320086.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Neutralizing SARS-CoV-2. A1 - Poeschla,Eric, Y1 - 2020/12/15/ PY - 2020/12/11/received PY - 2020/12/11/accepted PY - 2020/12/15/entrez PY - 2020/12/16/pubmed PY - 2020/12/29/medline KW - COVID-19 KW - SARS-CoV-2 KW - VSV KW - antibody KW - immunology KW - infectious disease KW - inflammation KW - microbiology KW - virus KW - viruses JF - eLife JO - Elife VL - 9 N2 - Experiments with hybrid viruses are illuminating how SARS-CoV-2 can escape neutralizing antibodies. SN - 2050-084X UR - https://www.unboundmedicine.com/medline/citation/33320086/Neutralizing_SARS_CoV_2_ L2 - https://doi.org/10.7554/eLife.64496 DB - PRIME DP - Unbound Medicine ER -